The discovery of CACNA2D1’s activation through episomal EBV DNA tethering to the human genome, leading to enhancer infestation, not only provides new insights into NPC pathogenesis but also opens avenues for targeted therapeutic interventions. The gene discussed is CACNA2D1; the disease is nasopharyngeal carcinoma.